Move to topTop
/covid-19/initiative/10
/covid-19/initiative/09
/covid-19/initiative/08
/covid-19/initiative/07
top_mainvisual_01_EN
top_mainvisual_01_s

Terumo Key Policies Regarding COVID-19

  1. 1.To protect the health and safety of all Terumo Associates with utmost priority.
  2. 2.To maintain a stable supply of products to continuously meet global healthcare needs.
  3. 3.To actively engage and contribute to the prevention and treatment of the disease, by maximizing Terumo Group's expertise and technologies.

Message from Management

Message from management image / Shinjiro Sato, President and CEO

We offer our deepest condolences for the people who have lost their lives during this time due to COVID-19, and pray for the recovery of others who have been afflicted by the virus.

 

With the three key policies of (1) ensuring the health and safety of all Terumo Associates, (2) maintaining a stable supply of products, and (3) actively contributing to prevention and treatment of the disease, the entire Terumo Group continues to work in the fight against COVID-19 to support medical professionals on the front lines and continue bringing treatment to patients.

 

Dr. Shibasaburo Kitasato, one of Terumo’s founders, dedicated his life to infectious disease prevention and microbiological research. Having inherited his DNA, Terumo has a long history of working to fight infectious diseases. In the COVID-19 crisis, we are reminded of the true meaning of our Group Mission of "Contributing to Society through Healthcare," and strongly feel a renewed sense of our purpose as a company—to keep working to bring solutions to medical settings.

 

In the post-COVID-19 world as well, the Terumo Group will continue to contribute to the health and safety globally.

 

President and CEO
Shinjiro Sato

Terumo Group Efforts

Learn more about our actions related to (responses to) COVID-19

#10 Main visual / Production line for vaccination syringes
#10
Supporting Vaccination Accessibility through Speedy Development and Production of Injection Syringes
#09 Main visual / Masked nurse disinfecting a hospital room
#09
Proposing solutions to address infection control needs in medical settings
#08 Main Visual / Illustration of a hand wrapping the earth in a mask by an associate family in India
#08
Creating an environment where associates can realize their potential, even during COVID-19
#07 Main Visual / Kazunori Hirose, Chief Manufacturing Officer (CMO)
#07
Maintaining a steady supply of products by promptly sharing information and making decisions without hesitation
#06 Main visual / ECMO manufacturing process
#06
Terumo Aims to Double ECMO Production and Supply
#05 Main Visual / Image of a woman listening to an online webinar
#05
Supporting Interventional Therapy During the COVID-19 Pandemic Webinar for Interventional Specialists in Southeast Asia
#04Main Visual / Associate working on the manufacturing process of blood component collection kits.
#04
Contributing to COVID-19 Treatment with Terumo Blood and Cell Technologies
#03 Main Visual / A ward of a temporary hospital in Brazil.
#03
Contributing to Brazil’s Urgent Medical Needs – Providing Support for Infusion Pump Systems in Temporary Hospitals
#02 Main Visual / A set of Terumo's relief supplies of ECMO in China
#02
Sending "Hope" with Collaboration Across Borders Swiftly Delivering ECMO to Patients in China
#01 Main Visual / Associates working as medical volunteers in Europe
#01
Supporting Associates with Medical Credentials in Volunteer Activities

Past Announcements on COVID-19

Donations

As the world joins together to support healthcare workers and others on the front lines providing critical care to patients, Terumo has donated over USD 4 million in cash and products to support the COVID-19 relief efforts worldwide - including a USD 2 million donation to the COVID-19 Solidarity Response Fund for WHO and donating a large number of digital thermometers and vital cardiopulmonary support systems (ECMO, or Extracorporeal Membrane Oxygenation) to medical institutions.

Sustainability at Terumo

Media Contact

Corporate Communication Dept., Terumo Corporation

Press Inquiries